🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary Objective: -To demonstrate the benefit of isatuximab in combinatio...
Status
Active Not Recruiting
Location
Investigational Site Number: 8400006
Start Date
2017-12-07
Trial ID
NCT03319667
Treatments Being Tested
The primary objective of this study is to assess the antitumor activity (in...
Status
Terminated
Location
Oncology Institute of Southern Switzerland (IOSI)
Start Date
2005-07
Trial ID
NCT00210392
Treatments Being Tested
Patients of relapsed and refractory warm autoimmune hemolytic anemia or EVA...
Status
Completed
Location
Peking Union Medical College Hospital
Start Date
2019-08-20
Trial ID
NCT04083014
Treatments Being Tested
This study will determine the safety profile, tolerability, and maximum tol...
Status
Completed
Location
H. Lee Moffitt Cancer Center
Start Date
2009-10-12
Trial ID
NCT00932698
Treatments Being Tested
Cyclophosphamide is a chemotherapy agent with known activity in myeloma. Th...
Status
Completed
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2008-09
Trial ID
NCT00750815
Treatments Being Tested
The primary objective of this study is to assess the antitumor activity (in...
Status
Completed
Location
Oncology Institute of Southern Switzerland (IOSI)
Start Date
2005-07
Trial ID
NCT00210327
Treatments Being Tested
The purpose of this study is to evaluate how tumors in patients with colore...
Status
Completed
Location
Cooper Green Hospital / Jefferson Clinic P.C.
Start Date
2002-12
Trial ID
NCT00051987
Treatments Being Tested
The primary objective is to evaluate the efficacy of desensitization therap...
Status
Terminated
Location
Cedars Sinai Heart Institute
Start Date
2013-06
Trial ID
NCT01769443
Treatments Being Tested
The purpose of this Phase 2 randomized study is to evaluate the efficacy an...
Status
Completed
Location
Wilhelminenspital-1
Start Date
2007-10
Trial ID
NCT00531453
Primary objective of the study is the determination of the maximum tolerate...
Status
Completed
Location
University Medical Center Freiburg
Start Date
2011-08
Trial ID
NCT01394354
Treatments Being Tested